Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2003-02-14
2009-08-25
McIntosh, III, Traviss C (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S183000, C536S007100, C536S007200, C536S007400
Reexamination Certificate
active
07579324
ABSTRACT:
This invention features a compound of the following formula:in-line-formulae description="In-line Formulae" end="lead"?T-(-L-C)m,in-line-formulae description="In-line Formulae" end="tail"?T is a transportophore, L is a bond or a linker having a molecular weight up to 240 dalton, C is a non-antibiotic therapeutic agent, and m is 1, 2, 3, 4, 5, 6, 7, or 8, in which the transportophore has an immune selectivity ratio of at least 2, the transportophore is covalently bonded to the non-antibiotic therapeutic agent via the bond or the linker, and the compound has an immune selectivity ratio of at least 2.
REFERENCES:
patent: 3417077 (1968-12-01), Murphy et al.
patent: 3884903 (1975-05-01), Jones et al.
patent: 4328334 (1982-05-01), Kobrehel et al.
patent: 4382086 (1983-05-01), Sciavolino et al.
patent: 4474768 (1984-10-01), Bright
patent: 4517359 (1985-05-01), Kobrehel et al.
patent: 4834973 (1989-05-01), Strahilevitz
patent: 5466681 (1995-11-01), Krivan et al.
patent: 5486536 (1996-01-01), Ward et al.
patent: 5516864 (1996-05-01), Kuhn et al.
patent: 5676971 (1997-10-01), Yoshioka et al.
patent: 5750493 (1998-05-01), Sommadossi et al.
patent: 5827533 (1998-10-01), Needham
patent: 5846458 (1998-12-01), Yoshioka et al.
patent: 5928868 (1999-07-01), Liu et al.
patent: 5969161 (1999-10-01), Bonnet et al.
patent: 6043227 (2000-03-01), Cheng et al.
patent: 6300316 (2001-10-01), Brightly et al.
patent: 6562796 (2003-05-01), Baldwin et al.
patent: 7091187 (2006-08-01), Mercep et al.
patent: 2003/0068362 (2003-04-01), Soon-Shiong et al.
patent: 0009944 (1980-04-01), None
patent: 0044090 (1982-01-01), None
patent: 0159856 (1985-10-01), None
patent: 0189281 (1986-07-01), None
patent: 0467331 (1992-01-01), None
patent: 0895999 (1999-02-01), None
patent: 0984019 (2000-03-01), None
patent: 0992509 (2000-04-01), None
patent: 1088828 (2001-04-01), None
patent: 1122261 (2001-08-01), None
patent: 1167376 (2002-01-01), None
patent: 1 036 083 (2004-05-01), None
patent: 05163293 (1993-06-01), None
patent: WO99/51616 (1999-10-01), None
patent: WO-99/63937 (1999-12-01), None
patent: WO-99/64032 (1999-12-01), None
patent: WO-99/64040 (1999-12-01), None
patent: WO-02/055531 (2002-07-01), None
patent: WO-03/045319 (2003-06-01), None
patent: WO-03/070173 (2003-08-01), None
patent: WO-03/070254 (2003-08-01), None
Goodman and Gilman's, “The Pharmacalogical Basis of Therapeutics”, 10th Edition, McGraw-Hill Medical Publishing Division, 2001, 54-57.
Shibata et al., “Relationship between erythrocyte-to-plasma distribution ratio of cyclosporin and lymphocyte proliferation in renal transplant patient”, Eur. J. Clin. Pharmacology (1997) vol. 51, p. 455-459.
Romo, D. et al., “Total Synthesis and Immunosuppressive Activity of (−)-Pateamine A and Related Compounds: Implementation of beta-Lactam Based MacroCclization,” Journal of the American Chemistry Society, American Chemical Society, Washington, DC, vol. 120, No. 47, 1998, pp. 12237-12254.
Griffith E.C. et al., “Yeast three-hybrid system for detecting ligand-receptor interactionsl” Methods in Enzymology, Academic Press Inc., San Diego, CA. vol. 328, 2000, pp. 89-103.
Costa, A. M. et al., “Hybrids of macrolides and nucleobases or nucleosides,” Tetrahedron Letters, Elsevier, Amsterdam, NL, vol. 41, No. 18, Apr. 2000, pp. 3371-3375.
Werner, R.G. et al., “Inhibition of protein synthesis by three erythromycin-derivatives,” Biochemical and Biophysical Research Communications Aug. 14, 1978, vol. 83, No. 3, pp. 1147-1156.
Ghosh, M. et al., “Design, synthesis, and biological evaluation of isocycnurate-based antifungal and macrolide antibiotic conjugates: iron transport-medicated drug delivery,” Bioorganic & Medicinal Chemistry Nov. 1995, vol. 3, No. 11, pp. 1519-1525.
Ianaro et al., “Anti-Inflammatory Activity of Macrolide Antibiotics”, Jan. 2000, J. Pharmacology and Experimental Therapeutics, vol. 292, No. 1, pp. 156-163.
Barker Laurence
Beck Albert
Burnet Michael
Busch Maximilian
Droste-Borel Irina
c-a-i-r biosciences GmbH
Edwards Angell Palmer & & Dodge LLP
Hsi Jeffrey D.
McIntosh, III Traviss C
LandOfFree
Conjugates of biologically active compounds, methods for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conjugates of biologically active compounds, methods for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugates of biologically active compounds, methods for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4083219